Grant: Institute of Genetics Clinical Investigatorship Award
McGill University
$280,000.00
The Role of Rare and Somatic Variants in Ageing-Related Disease
EF 2010-11
Résumé
Osteoporosis is a common and costly ageing-related disease. Approximately one third to one half of women will experience an osteoporotic fracture in their lifetime and the cost of just hip fractures is expected to rise to $2.4 billion per year in Canada by 2040 due to our ageing population. A main determinant of risk of osteoporotic fractures is inherited from our parents. While we have begun to describe the common genetic variants which influence risk of osteoporosis, we know that most of the genetic determinants are not common. Therefore this study aims to understand if rare genetic variation and genetic variation not inherited from our parents plays a role in the predisposition to osteoporosis and osteoporotic fracture. This study will broaden our understanding of this disease, provide new drug targets and may allow us to identify groups of individuals at risk for osteoporosis.
Programme
Institute of Genetics Clinical Investigatorship Award
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
209013
Name
Richards Brent
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Genetics Clinical Investigatorship
Projecttitle
The Role of Rare and Somatic Variants in Ageing-Related Disease
Programtype2
Salary Programs
Orgnameinp2
McGill University
Cihramount2
$280,000
Cihrequipment2
$0
Programname2
Institute of Genetics Clinical Investigatorship Award
Keyworddelim
Ageing; Epigenetic Modification; Genetic Epidemiology; Genomics; Osteoporosis; Rare Base Pair Variation; Somatic Mutation
Abstract
Osteoporosis is a common and costly ageing-related disease. Approximately one third to one half of women will experience an osteoporotic fracture in their lifetime and the cost of just hip fractures is expected to rise to $2.4 billion per year in Canada by 2040 due to our ageing population. A main determinant of risk of osteoporotic fractures is inherited from our parents. While we have begun to describe the common genetic variants which influence risk of osteoporosis, we know that most of the genetic determinants are not common. Therefore this study aims to understand if rare genetic variation and genetic variation not inherited from our parents plays a role in the predisposition to osteoporosis and osteoporotic fracture. This study will broaden our understanding of this disease, provide new drug targets and may allow us to identify groups of individuals at risk for osteoporosis.
Competitiondate
201007
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Richards, Brent
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $140,000~ $0~Institute of Genetics~ $140,000~ $0~